investing-statsSEC Form 4 insider transactions

EXEL · EXELIXIS, INC.

← all insiders

Biological Products, (No Diagnostic Substances) · Listed on Nasdaq

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades1
Distinct insiders1
Bought$0
Sold$526.5K
Net flow$-526.5K

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for EXEL
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-08-12Beckerle Mary CDirectorS sell10b5-19,8120$53.66$526.5K16,079−38%−<0.01% (now <0.01%)filing
2026-06-03WYSZOMIERSKI JACK LDirectorS sell10b5-13,9250$50.55$198.4K284,384−1%−<0.01% (now 0.11%)filing
2026-06-03Eckhardt Sue GailDirectorS sell10b5-19,8120$50.14$492.0K16,079−38%−<0.01% (now <0.01%)filing
2026-05-29PAPADOPOULOS STELIOSDirectorA buy8,36701,197,595+0.7%+<0.01% (now 0.48%)filing
2026-05-29Heyman Tomas J.DirectorA buy8,367050,649+20%+<0.01% (now 0.02%)filing
2026-05-29Eckhardt Sue GailDirectorA buy8,367025,891+48%+<0.01% (now 0.01%)filing
2026-05-29Smith JulieDirectorA buy8,367028,957+41%+<0.01% (now 0.01%)filing
2026-05-29Freire Maria CDirectorA buy8,3670109,186+8%+<0.01% (now 0.04%)filing
2026-05-29Oliver BobDirectorA buy8,367029,487+40%+<0.01% (now 0.01%)filing
2026-05-29WYSZOMIERSKI JACK LDirectorA buy8,3670288,309+3%+<0.01% (now 0.12%)filing
2026-05-29POSTE GEORGEDirectorA buy8,3670127,199+7%+<0.01% (now 0.05%)filing
2026-05-29JOHNSON DAVID EDWARD +1 moreDirector, Director, See RemarksA buy19,133 19,133 Common Stock19,133filing
2026-05-29Beckerle Mary CDirectorA buy8,367025,891+48%+<0.01% (now 0.01%)filing
2026-05-28Aftab DanaOfficer (EVP, Research and Development)S sell43,4510$50.35$2.19M594,741−7%−0.02% (now 0.24%)filing
2026-05-22Haley Patrick J.Officer (EVP, Commercial)S sell32,1100$49.81$1.60M357,638−8%−0.01% (now 0.14%)filing
2026-05-19MORRISSEY MICHAELDirector, Officer (President and CEO)G buy124,04702,004,327+7%+0.05% (now 0.81%)filing
2026-05-19MORRISSEY MICHAELDirector, Officer (President and CEO)G sell124,04701,362,008−8%−0.05% (now 0.55%)filing
2026-05-19MORRISSEY MICHAELDirector, Officer (President and CEO)F sell128,4970$51.10$6.57M1,486,055−8%−0.05% (now 0.60%)filing
2026-05-19Senner Christopher J.Officer (EVP and CFO)S sell34,9010$50.00$1.75M952,317−4%−0.01% (now 0.38%)filing
2026-05-19Senner Christopher J.Officer (EVP and CFO)F sell40,8920$51.10$2.09M987,218−4%−0.02% (now 0.40%)filing
2026-05-19Haley Patrick J.Officer (EVP, Commercial)F sell33,2650$51.10$1.70M389,748−8%−0.01% (now 0.16%)filing
2026-05-19Hefti BrendaOfficer (SVP and General Counsel)S sell10b5-16,6250$50.21$332.6K106,762−6%−<0.01% (now 0.04%)filing
2026-05-19Hefti BrendaOfficer (SVP and General Counsel)F sell10b5-16,4110$51.10$327.6K113,387−5%−<0.01% (now 0.05%)filing
2026-05-19Aftab DanaOfficer (EVP, Research and Development)F sell30,5780$51.10$1.56M638,192−5%−0.01% (now 0.26%)filing
2026-05-08Freire Maria CDirectorM sell20,634 20,634 Common Stock0filing
2026-05-08Freire Maria CDirectorS sell20,6340$46.00$949.2K100,819−17%−<0.01% (now 0.04%)filing
2026-05-08Freire Maria CDirectorM buy20,6340$19.77$407.9K121,453+20%+<0.01% (now 0.05%)filing
2026-05-08POSTE GEORGEDirectorS sell60,0000$45.71$2.74M118,832−34%−0.02% (now 0.05%)filing
2026-05-08MORRISSEY MICHAELDirector, Officer (President and CEO)G sell109,67601,880,280−6%−0.04% (now 0.76%)filing
2026-05-08Beckerle Mary CDirectorM sell3,856 3,856 Common Stock12,854filing
2026-05-08Beckerle Mary CDirectorS sell7,7120$48.45$373.6K17,524−31%−<0.01% (now <0.01%)filing
2026-05-08Beckerle Mary CDirectorM buy3,8560$23.24$89.6K25,236+18%+<0.01% (now 0.01%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.